Stockreport

Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF Completed in-license agreement with Cornell University for intellectual property rights, including current and future clinical data from an ongoing investigator-initiat [Read more]